ProfileGDS4718 / 204608_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 97% 82% 97% 96% 94% 95% 97% 96% 97% 97% 95% 98% 89% 95% 97% 96% 92% 92% 89% 97% 97% 97% 97% 96% 96% 96% 88% 96% 91% 95% 89% 97% 97% 95% 95% 96% 96% 97% 79% 97% 94% 94% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.09697
GSM549102patient 115, normal, homogenized [OPG study]11.202597
GSM549104patient 119, normal, homogenized [OPG study]8.2219882
GSM549108patient 138, normal, homogenized [OPG study]11.062197
GSM549119patient 077, normal, homogenized [OPG study]10.475696
GSM549133patient 032, cancer, homogenized [OPG study]9.9936794
GSM549139patient 042, cancer, homogenized [OPG study]10.207895
GSM549099patient 107, normal, homogenized [OPG study]10.850997
GSM549109patient 139, normal, homogenized [OPG study]10.543896
GSM549110patient 046, normal, homogenized [OPG study]11.029297
GSM549114patient 063, normal, homogenized [OPG study]11.193697
GSM549122patient 082, normal, homogenized [OPG study]10.379495
GSM549134patient 033, cancer, homogenized [OPG study]11.445698
GSM549136patient 036, cancer, homogenized [OPG study]9.082489
GSM549140patient 044, cancer, homogenized [OPG study]10.089195
GSM549111patient 047, normal, homogenized [OPG study]10.994797
GSM549113patient 057, normal, homogenized [OPG study]10.902996
GSM549132patient 031, cancer, homogenized [OPG study]9.4675692
GSM549137patient 038, cancer, homogenized [OPG study]9.4148892
GSM549142patient 047, cancer, homogenized [OPG study]8.5572489
GSM549100patient 110, normal, homogenized [OPG study]11.023197
GSM549107patient 135, normal, homogenized [OPG study]11.08897
GSM549115patient 068, normal, homogenized [OPG study]11.266997
GSM549116patient 072, normal, homogenized [OPG study]11.019497
GSM549120patient 078, normal, homogenized [OPG study]10.646696
GSM549131patient 030, cancer, homogenized [OPG study]10.408396
GSM549118patient 074, normal, homogenized [OPG study]10.676396
GSM549129patient 027, cancer, homogenized [OPG study]8.786388
GSM549123patient 088, normal, homogenized [OPG study]10.744496
GSM549124patient 006, cancer, homogenized [OPG study]9.3060891
GSM549126patient 015, cancer, homogenized [OPG study]10.245895
GSM549128patient 025, cancer, homogenized [OPG study]9.0113189
GSM549103patient 117, normal, homogenized [OPG study]10.890497
GSM549117patient 073, normal, homogenized [OPG study]11.145897
GSM549138patient 041, cancer, homogenized [OPG study]10.179595
GSM549141patient 045, cancer, homogenized [OPG study]10.285595
GSM549130patient 028, cancer, homogenized [OPG study]10.454596
GSM549101patient 111, normal, homogenized [OPG study]10.58696
GSM549105patient 128, normal, homogenized [OPG study]10.960597
GSM549106patient 134, normal, homogenized [OPG study]7.8557779
GSM549112patient 048, normal, homogenized [OPG study]11.053297
GSM549125patient 011, cancer, homogenized [OPG study]9.8007194
GSM549127patient 024, cancer, homogenized [OPG study]9.872394
GSM549135patient 035, cancer, homogenized [OPG study]9.7315993